Evropska unija - slovenščina - EMA (European Medicines Agency)

merck sharp & dohme b.v.  - ceftolozane sulfat, tazobactam natrijev - bakterijske okužbe - antibacterials za sistemsko uporabo, - zerbaxa is indicated for the treatment of the following infections in adults:complicated intra abdominal infections;acute pyelonephritis;complicated urinary tract infections;hospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap). upoštevati je treba uradne smernice za ustrezno uporabo protibakterijsko agenti.

Evropska unija - slovenščina - EMA (European Medicines Agency)

intervet international b.v. - cepivo proti bolezni modrikastega jezika, serotip 8 (inaktiviran) - imunologija za ovide - cattle; sheep - sheepfor aktivno imunizacijo ovc od 2. starost 5 mesecev za preprečevanje viremije * in zmanjšanje kliničnih znakov, ki jih povzroča serotip 8 virusa bolezni modrikastega jezika. cattlefor aktivno imunizacijo goveda (od 2. starost 5 mesecev, da preprečite viremijo *, ki jo povzroča virus seruma 8 bolezni modrikastega jezika. * (kolesarska vrednost (ct) ≥ 36 z validirano metodo rt-pcr, ki nima prisotnosti virusnega genoma).

Evropska unija - slovenščina - EMA (European Medicines Agency)

pfizer europe ma eeig - gemtuzumab ozogamicin - leukemija, myeloid, akutna - antineoplastična sredstva - mylotarg je označen za kombiniranega zdravljenja z daunorubicin (dnr) in cytarabine (arac) za zdravljenje bolnikov v starosti 15 let in več s predhodno nezdravljenih, de novo cd33-pozitivno akutno mieloično levkemijo (aml), razen akutna promyelocytic levkemijo (apl).

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

zoetis belgium sa rue laid burniat 1 1348 louvain -

Evropska unija - slovenščina - EMA (European Medicines Agency)

glaxosmithkline biologicals sa - recombinant varicella zoster virus glycoprotein e - herpes zoster - cepiva - shingrix is indicated for prevention of herpes zoster (hz) and post-herpetic neuralgia (phn), in:adults 50 years of age or older;adults 18 years of age or older at increased risk of hz. uporaba shingrix mora biti v skladu z uradnimi priporočili.

Evropska unija - slovenščina - EMA (European Medicines Agency)

atnahs pharma netherlands b.v. - macimorelin acetat - diagnostične tehnike, endokrine - macimorelin - to zdravilo je samo za diagnostično uporabo.  ghryvelin is indicated for the diagnosis of growth hormone deficiency (ghd) in adults.

Evropska unija - slovenščina - EMA (European Medicines Agency)

zoetis belgium sa - selamectin, sarolaner - antiparazitni izdelki, insekticidi in repelenti - mačke - za mačke z ali brez nevarnosti mešanih parazitskih napadov s klopi in bolhami, uši, pršicami, gastrointestinalnimi ogorčicami ali srčnim črvom. zdravilo za uporabo v veterinarski medicini je izključno označeno, kadar je uporaba proti klopom istočasno označena z enim ali več drugimi ciljnimi paraziti..

Evropska unija - slovenščina - EMA (European Medicines Agency)

janssen-cilag international n.v.    - recombinant adenovirus type 26 (ad26) encoding the glycoprotein (gp) of the ebola virus zaire (zebov) mayinga strain - hemoragične mrzlice, ebola - cepiva - active immunization for prevention of disease caused by ebola virus (zaire ebolavirus species) in individuals ≥ 1 year of age.

Evropska unija - slovenščina - EMA (European Medicines Agency)

janssen-cilag international n.v.    - recombinant modified vaccinia ankara bavarian nordic virus encoding the: ebola virus zaire (zebov) mayinga strain glycoprotein (gp); ebola virus sudan gulu strain gp; ebola virus taï forest strain nucleoprotein and the marburg virus musoke strain gp - hemoragične mrzlice, ebola - cepiva - active immunization for prevention of disease caused by ebola virus (zaire ebolavirus species) in individuals ≥ 1 year of age.

Evropska unija - slovenščina - EMA (European Medicines Agency)

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - cepiva - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. uporaba tega cepiva mora biti v skladu z uradnimi priporočili.